SFX by Ex Libris Inc.

Title:	Broadly neutralizing antibodies present new prospects to counter highly antigenically diverse viruses
Source:	Science [0036-8075] Burton, D R yr:2012

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	John, L. "Metagenomics and future perspectives in virus discovery." Current Opinion in Virology 2.1 (2012): 63-77.
description	2.	Saunders, Kevin O. "The design and evaluation of HIV-1 vaccines." AIDS 26.10 (2012): 1293-1302.
description	3.	Burton, Dennis R R. "Antibodies, viruses and vaccines." Nature reviews. Immunology 2.9 (2002): 706-13.
description	4.	Stamatatos, L. "Neutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?" Nature Medicine 15.8 (2009): 866-70.
description	5.	Keele, B. "Identification and characterisation of transmitted and early founder virus envelopes in primary HIV-1 infection." Proceedings of the National Academy of Sciences of the United States of America 105.21 (2008): 7552-7557.
description	6.	Crawford, Dorothy H H. "Epstein-Barr virus-recent advances." The Lancet infectious diseases 3.3 (2003): 131-140.
description	7.	Breitbart, K. "Exploring the viral world through metagenomics." Current Opinion in Virology 1.4 (2011): 289-297.
description	8.	Bexfield, N. "Metagenomics and the molecular identification of novel viruses." The veterinary journal 190.24 (2010): 191-198.
description	9.	Ganem, D. "Hepatitis B virus infection--natural history and clinical consequences." The New England journal of medicine 350.11 (2004): 1118-29.
description	10.	Roossinck, Marilyn J. "Plant Virus Metagenomics: Biodiversity and Ecology." Annual review of genetics 46.1 (2012): 359-369.
description	11.	Girard, Marc P. "Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: A review." Vaccine 29.37 (2011): 6191-6218.
description	12.	De Clercq, E. "Antivirals and antiviral strategies." Nature reviews. Microbiology 2.9: 704-720.
description	13.	Burton, Dennis R. "Rational antibody-based HIV-1 vaccine design: current approaches and future directions." Current opinion in immunology 22.3 (2010): 358-366.
description	14.	Szarewski, A. "Efficacy of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine in women aged 15-25 years with and without serological evidence of previous exposure to HPV-16/18." International journal of cancer 131.1 (2011): 106-116.
description	15.	Inskeep, William P. "Metagenomes from high-temperature chemotrophic systems reveal geochemical controls on microbial community structure and function." PLoS ONE 5.3 (2010).
description	16.	Coffman, Robert L. "Vaccine adjuvants: putting innate immunity to work." Immunity 33.4 (2010): 492-503.
description	17.	Barouch, Dan H. "HIV-1 vaccine development after STEP." Annual Review of Medicine 61.1 (2010): 153-167.
description	18.	Montefiori, Guido C. "Neutralizing and other antiviral antibodies in HIV-1 infection and vaccination." Current opinion in HIV and AIDS 2.3 (2007): 169-176.
description	19.	Anderson, J. "Quantitating the Multiplicity of Infection with Human Immunodeficiency Virus Type 1 Subtype C Reveals a Non-Poisson Distribution of Transmitted Variants." Journal of virology 83.8 (2009): 3556-3567.
description	20.	Church, Jessica D. "HIV-1 tropism and survival in vertically infected Ugandan infants." The journal of infectious diseases 197.10 (2008): 1382-8.